Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
Erasmus MC Academic Center for Thyroid Diseases, Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
Thyroid. 2023 Mar;33(3):301-311. doi: 10.1089/thy.2022.0373. Epub 2023 Mar 1.
Thyroid hormones play a key role in differentiation and metabolism and are known regulators of gene expression through both genomic and epigenetic processes including DNA methylation. The aim of this study was to examine associations between thyroid hormones and DNA methylation. We carried out a fixed-effect meta-analysis of epigenome-wide association study (EWAS) of blood DNA methylation sites from 8 cohorts from the ThyroidOmics Consortium, incorporating up to 7073 participants of both European and African ancestry, implementing a discovery and replication stage. Statistical analyses were conducted using normalized beta CpG values as dependent and log-transformed thyrotropin (TSH), free thyroxine, and free triiodothyronine levels, respectively, as independent variable in a linear model. The replicated findings were correlated with gene expression levels in whole blood and tested for causal influence of TSH and free thyroxine by two-sample Mendelian randomization (MR). Epigenome-wide significant associations (-value <1.1E-7) of three CpGs for free thyroxine, five for free triiodothyronine, and two for TSH concentrations were discovered and replicated (combined -values = 1.5E-9 to 4.3E-28). The associations included CpG sites annotated to (cg00049440) and (cg04173586) that overlap with all three traits, consistent with hypothalamic-pituitary-thyroid axis physiology. Significant associations were also found for CpGs in for free thyroxine, and at and for free triiodothyronine. MR analyses supported a causal effect of thyroid status on DNA methylation of . DNA methylation of cg00049440 in was inversely correlated with gene expression in blood. The CpG at overlapped with thyroid hormone receptor alpha binding peaks in liver cells. The total additive heritability of the methylation levels of the six significant CpG sites was between 25% and 57%. Significant methylation QTLs were identified for CpGs at , , , and . We report novel associations between TSH, thyroid hormones, and blood-based DNA methylation. This study advances our understanding of thyroid hormone action particularly related to and serves as a proof-of-concept that integrations of EWAS with other -omics data can provide a valuable tool for unraveling thyroid hormone signaling in humans by complementing and feeding classical and animal studies.
甲状腺激素在分化和代谢中起着关键作用,已知其通过基因组和表观遗传过程(包括 DNA 甲基化)调节基因表达。本研究旨在探讨甲状腺激素与 DNA 甲基化之间的关联。我们对甲状腺代谢组学联盟 8 个队列的血液 DNA 甲基化位点进行了固定效应荟萃分析,纳入了欧洲和非洲血统的 7073 名参与者,实施了发现和复制阶段。统计分析使用标准化 betaCpG 值作为因变量,对数转换的促甲状腺激素(TSH)、游离甲状腺素和游离三碘甲状腺原氨酸水平分别作为线性模型中的自变量。复制的发现与全血中的基因表达水平相关,并通过两样本孟德尔随机化(MR)测试 TSH 和游离甲状腺素的因果影响。发现并复制了与游离甲状腺素(-值<1.1E-7)三个 CpG、游离三碘甲状腺原氨酸(-值<1.1E-7)五个 CpG 和 TSH 浓度(-值<1.1E-7)三个 CpG 的表观基因组显著关联(合并-值=1.5E-9 至 4.3E-28)。这些关联包括注释为 (cg00049440)和 (cg04173586)的 CpG 位点,与所有三个特征重叠,与下丘脑-垂体-甲状腺轴生理学一致。在游离甲状腺素的 CpG 中也发现了显著关联,在游离三碘甲状腺原氨酸的 CpG 中也发现了 CpG 在 和 CpG 在 和 的关联。MR 分析支持甲状腺状态对 DNA 甲基化的因果影响。位于 中的 cg00049440 的 DNA 甲基化与血液中 基因的表达呈负相关。位于 中的 CpG 与肝细胞中甲状腺激素受体α结合峰重叠。六个显著 CpG 位点的甲基化水平的总加性遗传率在 25%到 57%之间。为 CpGs 鉴定了显著的甲基化 QTL,这些 CpGs 位于 、 、 、和 。我们报告了 TSH、甲状腺激素和血液中 DNA 甲基化之间的新关联。本研究加深了我们对甲状腺激素作用的理解,特别是与 有关,并且通过补充和扩展经典的 和动物研究,证明了将 EWAS 与其他 -omics 数据相结合可以为人类甲状腺激素信号转导提供有价值的工具。